1月1日晚间,上海医药(SH601607,股价21.00元,市值778.61亿元)公告称,公司拟联合上海金浦健服股权投资管理有限公司指定主体共同收购上海和黄医药投资(香港)有限公司(以下简称“和黄医药”)持有的上海和黄药业有限公司(以下简称“上海和黄药业”)股权,其中上海医药拟以9.95亿元收购10%股权。据悉,上海和黄药业由上海医药全资子公司上海市药材有限公司与和黄医药合资设立,双方各持股50%...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.